HomeBIOV • CNSX
add
Biovaxys Technology Corp
Previous close
$0.055
Day range
$0.055 - $0.060
Year range
$0.040 - $0.10
Market cap
15.10M CAD
Avg Volume
513.60K
P/E ratio
-
Dividend yield
-
Primary exchange
CNSX
In the news
Financials
Income Statement
Revenue
Net income
| (CAD) | Jul 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 802.19K | 128.86% |
Net income | -1.19M | 58.00% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Jul 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 490.84K | 115,939.01% |
Total assets | 2.41M | 70.44% |
Total liabilities | 2.66M | 30.44% |
Total equity | -249.20K | — |
Shares outstanding | 256.03M | — |
Price to book | ∞ | — |
Return on assets | -96.10% | — |
Return on capital | 355.54% | — |
Cash Flow
Net change in cash
| (CAD) | Jul 2024info | Y/Y change |
|---|---|---|
Net income | -1.19M | 58.00% |
Cash from operations | -412.20K | -1,636.08% |
Cash from investing | -1.00 | — |
Cash from financing | 743.40K | — |
Net change in cash | 331.10K | 1,280.20% |
Free cash flow | -953.42K | -411.84% |
About
Headquarters
Website
